Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness

被引:25
作者
Blot, E
Chen, W
Vasse, M
Paysant, J
Denoyelle, C
Pillé, JY
Vincent, L
Vannier, JP
Soria, J
Soria, C
机构
[1] Ctr Henri Becquerel, Dept Med Oncol, F-76038 Rouen 1, France
[2] Med & Pharm Fac, DIFEMA Lab, F-76183 Rouen, France
[3] Hop Hotel Dieu, INSERM EMI 9912, F-75004 Paris, France
[4] Hop Hotel Dieu, St Marie Labs, F-75004 Paris, France
[5] Hop St Louis, INSERM U353, F-75010 Paris, France
关键词
breast cancer; monocytes; inflammation; cytokine; invasiveness factors;
D O I
10.1038/sj.bjc.6600872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In breast cancers, clinical symptoms of inflammation localised around the tumour at the time of diagnosis have been considered to have poor prognosis significance. In this study, the biological mechanisms responsible for the deleterious action of monocytes in cancer were investigated. The incubation of the breast-cancer-derived MDA-MB231 cells with monocytes resulted in an increase in factors involved in cell invasion (i.e. both cancer cells and monocytes-associated urokinase and Tissue Factor, and PAI-1 and MMP-9 secretion). Moreover, the functions of monocytes were also modified. Incubation of monocytes with MDA-MB231 cancer cells resulted in a downregulation in the secretion of the antiproliferative cytokine Oncostatin M, while the apoptotic factor TNF alpha was dramatically increased. However, MDA-MB231 cancer cells have been shown to be resistant towards the apoptotic action of TNF alpha. These findings demonstrate that incubation of MDA-MB231 cancer cells with monocytes induced a crosstalk, which resulted in an increased expression of factors involved in cancer cell invasiveness and in a modification of monocytes function against cancer cells, while inflammatory effects were increased. (C) 2003 Cancer Research UK.
引用
收藏
页码:1207 / 1212
页数:6
相关论文
共 44 条
  • [1] Amirkhosravi A, 1998, THROMB HAEMOSTASIS, V80, P598
  • [2] Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
  • [3] 2-Z
  • [4] Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
    Bajou, K
    Noël, A
    Gerard, RD
    Masson, V
    Brunner, N
    Holst-Hansen, C
    Skobe, M
    Fusenig, NE
    Carmeliet, P
    Collen, D
    Foidart, JM
    [J]. NATURE MEDICINE, 1998, 4 (08) : 923 - 928
  • [5] Chamberlain J., 1997, Health Technol Assess, V1, P1
  • [6] CHEVALLIER B, 1993, B CANCER, V80, P1024
  • [7] Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study
    Denoyelle, C
    Vasse, M
    Körner, M
    Mishal, Z
    Ganné, F
    Vannier, JP
    Soria, J
    Soria, C
    [J]. CARCINOGENESIS, 2001, 22 (08) : 1139 - 1148
  • [8] Etoh T, 2000, CLIN CANCER RES, V6, P3545
  • [9] Frandsen TL, 2001, CANCER RES, V61, P532
  • [10] STUDY OF PROTEASES AND PROTEASE-INHIBITOR COMPLEXES IN BIOLOGICAL-FLUIDS
    GRANELLIPIPERNO, A
    REICH, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) : 223 - 234